| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.096 | 0.06 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.06 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.06 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.06 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.06 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.06 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.076 | 0.06 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.06 |